| (Values in U.S. Thousands) | Aug, 2025 | Aug, 2024 | Aug, 2023 | Aug, 2022 | Aug, 2021 |
| Sales | -175 | 40,140 | 8,494 | -21,104 | 29,122 |
| Sales Growth | -100.44% | +372.57% | +140.25% | -172.47% | -46.71% |
| Net Income | -1,170 | 38,876 | 6,813 | -22,473 | 27,885 |
| Net Income Growth | -103.01% | +470.62% | +130.32% | -180.59% | -47.80% |
International Biotechnology Trust Plc (IBT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
Fiscal Year End Date: 08/31